This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignees: Irbm S.p.a., Istituto Nazionale Di Genetica Molecolare - Ingm, Ospedale San Raffaele S.r.l.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 56 
Years Active: 2025
Title: Vincenzo Summa: Innovator in Hepatitis B Virus Research
Introduction
Vincenzo Summa is an inventor based in Pomezia (RM), Italy. He has made significant contributions to the field of medical research, particularly in the area of hepatitis B virus (HBV) treatment. Although he currently holds no granted patents, his work is noteworthy for its potential impact on public health.
Latest Patent Applications
Vincenzo Summa has filed several patent applications related to his research. One of his latest applications is for "Inhibitors of Hepatitis B Virus." This invention pertains to compounds that act as inhibitors of HBV. These compounds are useful alone or in combination with other agents for treating, ameliorating, preventing, or curing HBV infection and related conditions. The application also includes pharmaceutical compositions containing these compounds. Another significant application is for "Oxalamido-Substituted Tricyclic Inhibitors of Hepatitis B Virus," which shares similar objectives and applications as the previous one.
Conclusion
Vincenzo Summa's innovative work in the field of hepatitis B virus research highlights his commitment to advancing medical science. His ongoing efforts in developing effective treatments could play a crucial role in combating HBV infections in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile